ANCA-associated lung fibrosis: Analysis of 17 patients

Respiratory Medicine

Volumn 102, Issue 10, 2008, Pages 1392-1398

  Foulon, Guillaume ^a   Delaval, Philippe ^b   Valeyre, Dominique ^c   Wallaert, Benoît ^d   Debray, Marie Pierre ^a   Brauner, Michel ^c   Nicaise, Pascale ^a   Cadranel, Jacques ^e   Cottin, Vincent ^f   Tazi, Abdellatif ^g   Aubier, Michel ^a,h   Crestani, Bruno ^a,h  

^a BICHAT HOSPITAL   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e HÔPITAL TENON   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h INSERM   (France)

Author keywords

Antibodies; Antineutrophil cytoplasmic; Autoimmunity; Fibrosing alveolitis; Microscopic polyangiitis; Vasculitis

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CARBON MONOXIDE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INFLIXIMAB; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG CAPACITY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; MICROSCOPIC POLYANGIITIS; NEUTROPHIL COUNT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VASCULITIS; VITAL CAPACITY;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SMOKING; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; VASCULITIS;

EID: 50549096630     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.04.023     Document Type: Article

References (25)

1. Lauque D., Cadranel J., Lazor R., Pourrat J., Ronco P., Guillevin L., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 79 4 (2000) 222-233
2. Gallagher H., Kwan J.T., and Jayne D.R. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 39 1 (2002) 42-47
3. Hiromura K., Nojima Y., Kitahara T., Ueki K., Maezawa A., Kawai H., et al. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis. Clin Nephrol 53 5 (2000) 384-389
4. Mansi I.A., Opran A., Sondhi D., Ayinla R., and Rosner F. Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis: is anti-neutrophilic cytoplasmic antibody testing indicated?. Am J Med Sci 321 (2001) 201-202
5. Nada A.K., Torres V.E., Ryu J.H., Lie J.T., and Holley K.E. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 65 6 (1990) 847-856
6. Becker-Merok A., Nossent J.C., and Ritland N. Fibrosing alveolitis predating microscopic polyangiitis. Scand J Rheumatol 28 (1999) 254-256
7. Souid M., Terki N.H., Nochy D., and Hillion D. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution. Clin Nephrol 55 (2001) 337-338
8. Eschun G.M., Mink S.N., and Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 123 1 (2003) 297-301
9. Gaudin P.B., Askin F.B., Falk R.J., and Jennette J.C. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104 1 (1995) 7-16
10. Gal A.A., Salinas F.F., and Staton Jr. G.W. The clinical and pathological spectrum of antineutrophil cytoplasmic autoantibody-related pulmonary disease. A comparison between perinuclear and cytoplasmic antineutrophil cytoplasmic autoantibodies. Arch Pathol Lab Med 118 12 (1994) 1209-1214
11. Jennette J.C., Wilkman A.S., and Falk R.J. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135 5 (1989) 921-930
12. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 (2000) 646-664
13. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 2 (1994) 187-192
14. Kazerooni E.A., Martinez F.J., Flint A., Jamadar D.A., Gross B.H., Spizarny D.L., et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR 169 (1997) 977-983
15. Homma S., Matsushita H., and Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 9 2 (2004) 190-196
16. Wallace W.A., Roberts S.N., Caldwell H., Thornton E., Greening A.P., Lamb D., et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 49 (1994) 218-222
17. Singh S., and du Bois R. Autoantibodies in cryptogenic fibrosing alveolitis. Respir Res 2 2 (2001) 61-63
18. Marchal-Somme J., Uzunhan Y., Marchand-Adam S., Valeyre D., Soumelis V., Crestani B., et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 176 10 (2006) 5735-5739
19. Robinson C., Callow M., Stevenson S., Robinson B., and Lake R. Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis. Respir Res 2 2 (2001) 119-124
20. Kinder B.W., Collard H.R., Koth L., Daikh D.I., Wolters P.J., Elicker B., et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 176 7 (2007) 691-697
21. Kanazawa M., Tokunaga D., Sato N., Kurashima K., and Takayanagi N. Incidence, clinical pictures and courses of patients with MPO-ANCA positive interstitial pneumonia (IP) of unknown etiology. Eur Respir J 24 Suppl. 48 (2004) 505s (abstract)
22. Haegens A., van der Vliet A., Butnor K.J., Heintz N., Taatjes D., Hemenway D., et al. Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res 65 21 (2005) 9670-9677
23. Mahadeva R., Zhao M.H., Stewart S., Cary N., Flower C., and Lockwood M. Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency. Chest 112 6 (1997) 1699-1701
24. Cambridge G., Williams M., Leaker B., Corbett M., and Smith C.R. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheum Dis 53 1 (1994) 24-29
25. Braun M.G., Csernok E., Schmitt W.H., and Gross W.L. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 23 5 (1996) 826-830